ReviewCNS drugs2018
From LBR-101 to Fremanezumab for Migraine.
Marcelo E Bigal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled ittrialcites it
ReviewCNS drugs2018
Marcelo E Bigal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.